Grainne Quinn is EVP, Chief Medical Officer of PERRIGO Co plc. Currently has a direct ownership of 21,078 shares of PRGO, which is worth approximately $539,386. The most recent transaction as insider was on Mar 07, 2024, when has been sold 1,170 shares (Ordinary Shares) at a price of $29.69 per share, resulting in proceeds of $34,737. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K
0% 3M change
49.88% 12M change
Total Value Held $539,386

Grainne Quinn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2024
SELL
Payment of exercise price or tax liability
$34,737 $29.69 p/Share
1,170 Reduced 5.26%
21,078 Ordinary Shares
Mar 07 2024
BUY
Exercise of conversion of derivative security
$66,772 $29.69 p/Share
2,249 Added 9.18%
22,248 Ordinary Shares
Mar 06 2024
SELL
Payment of exercise price or tax liability
$25,702 $28.09 p/Share
915 Reduced 4.38%
19,999 Ordinary Shares
Mar 06 2024
BUY
Exercise of conversion of derivative security
$49,410 $28.09 p/Share
1,759 Added 7.76%
20,914 Ordinary Shares
Mar 05 2024
SELL
Payment of exercise price or tax liability
$150,447 $27.26 p/Share
5,519 Reduced 22.37%
19,155 Ordinary Shares
Mar 05 2024
BUY
Grant, award, or other acquisition
$246,103 $27.26 p/Share
9,028 Added 27.46%
23,850 Ordinary Shares
Mar 05 2024
BUY
Exercise of conversion of derivative security
$43,152 $27.26 p/Share
1,583 Added 9.19%
15,646 Ordinary Shares
Mar 07 2023
SELL
Payment of exercise price or tax liability
$44,120 $37.71 p/Share
1,170 Reduced 7.68%
14,063 Ordinary Shares
Mar 07 2023
BUY
Exercise of conversion of derivative security
$84,847 $37.71 p/Share
2,250 Added 12.87%
15,233 Ordinary Shares
Mar 03 2023
SELL
Payment of exercise price or tax liability
$162,362 $38.75 p/Share
4,190 Reduced 24.4%
12,983 Ordinary Shares
Mar 03 2023
BUY
Exercise of conversion of derivative security
$102,145 $38.75 p/Share
2,636 Added 16.03%
13,807 Ordinary Shares
Mar 03 2023
BUY
Grant, award, or other acquisition
$209,986 $38.75 p/Share
5,419 Added 27.15%
14,537 Ordinary Shares
Dec 16 2022
SELL
Open market or private sale
$74,947 $31.65 p/Share
2,368 Reduced 20.62%
9,118 Ordinary Shares
Mar 04 2022
SELL
Payment of exercise price or tax liability
$191,176 $37.23 p/Share
5,135 Reduced 30.89%
11,486 Ordinary Shares
Mar 04 2022
BUY
Exercise of conversion of derivative security
$143,782 $37.23 p/Share
3,862 Added 23.88%
12,310 Ordinary Shares
Mar 04 2022
BUY
Grant, award, or other acquisition
$223,678 $37.23 p/Share
6,008 Added 32.01%
12,759 Ordinary Shares
Mar 08 2021
SELL
Payment of exercise price or tax liability
$45,291 $41.82 p/Share
1,083 Reduced 16.07%
5,658 Ordinary Shares
Mar 08 2021
BUY
Grant, award, or other acquisition
$87,069 $41.82 p/Share
2,082 Added 23.6%
6,741 Ordinary Shares
Mar 05 2021
SELL
Payment of exercise price or tax liability
$48,673 $41.04 p/Share
1,186 Reduced 14.94%
6,751 Ordinary Shares
Mar 05 2021
BUY
Exercise of conversion of derivative security
$93,530 $41.04 p/Share
2,279 Added 23.79%
7,299 Ordinary Shares
GQ

Grainne Quinn

EVP, Chief Medical Officer
Allegan, MI

Track Institutional and Insider Activities on PRGO

Follow PERRIGO Co plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRGO shares.

Notify only if

Insider Trading

Get notified when an Perrigo CO PLC insider buys or sells PRGO shares.

Notify only if

News

Receive news related to PERRIGO Co plc

Track Activities on PRGO